Informes de trasplantes: acceso abierto

Abstracto

Adrenalectomy for Bilateral Metachronous Adrenal Recurrence of Hepatocellular Carcinoma after Liver Transplant

David L Morris

Hepatocellular melanoma is the fifth most common cancer in the world and the third leading cause of cancerrelated death. It's presently one of the leading suggestions for liver transplant, with named 5- time survival rates after liver transplant of about 70. Despite excellent results of liver transplant for hepatocellular melanoma, a number of cases develop metastases after transplant, and multifocal metastatic complaint is the most frequent cause of death. In a large necropsy series of cases with hepatocellular melanoma, adrenal glands were the third most common point of extra hepatic metastasis after lungs and bones. Still, insulated metastatic complaint in the adrenal glands is rare, and insulated Metachronous bilateral metastasis is an indeed rarer circumstance. Only many reports have been published of Metachronous bilateral metastasis of hepatocellular carcinoma after liver transplant treated with bilateral Adrenalectomy. We describe a case of a 56- time-old man who passed liver transplant for hepatocellular melanoma in a cirrhotic liver. Two times after liver transplant, regular follow- up revealed metastatic complaint in the left adrenal gland. Preoperative imaging showed no other metastasis, and he passed an uneventful left Adrenalectomy. A time after surgery, he presented with right hand pain and tender-heartedness. Imaging showed haemorrhage and excrescence involvement of the right adrenal gland, and he passed right Adrenalectomy. Two times after surgery, he's alive and well with no signs of complaint rush. Supposedly, in the absence of intrahepatic or other metastases, bilateral Metachronous rush of hepatocellular melanoma after liver transplant can be a good surgical suggestion with respectable long- term survival [1-2].